May 2004
Volume 45, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2004
Anti–inflammatory lipid mediators markedly accelerate wound healing and inhibit neo–vascularization: Evidence for novel protective lipid circuits in the cornea.
Author Affiliations & Notes
  • K. Gronert
    Pharmacology, New York Med Coll, Valhalla, NY
  • N. Maheshwari
    Pharmacology, New York Med Coll, Valhalla, NY
  • S. Tresker
    Pharmacology, New York Med Coll, Valhalla, NY
  • M. Laniado Schwartzman
    Pharmacology, New York Med Coll, Valhalla, NY
  • M. Dunn
    Pharmacology, New York Med Coll, Valhalla, NY
  • Footnotes
    Commercial Relationships  K. Gronert, None; N. Maheshwari, None; S. Tresker, None; M. Laniado Schwartzman, None; M. Dunn, None.
  • Footnotes
    Support  none
Investigative Ophthalmology & Visual Science May 2004, Vol.45, 1164. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      K. Gronert, N. Maheshwari, S. Tresker, M. Laniado Schwartzman, M. Dunn; Anti–inflammatory lipid mediators markedly accelerate wound healing and inhibit neo–vascularization: Evidence for novel protective lipid circuits in the cornea. . Invest. Ophthalmol. Vis. Sci. 2004;45(13):1164.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Abstract: : Purpose: Injury to the cornea leads to formation of distinct classes of mediators that initiate and amplify inflammatory cascades and neo–vascularization. However, endogenous pathways that counter–regulate these signals and minimize corneal damage remain to be elucidated. To this end, we assessed whether recently described novel anti–inflammatory lipid circuits, namely the Lipoxin A4 and the docosahexaenoic acid (DHA)–initiated 17S–resolvin circuit, are present in the cornea and have a role in keratitis, wound healing and/or neo–vascularization. Methods: Corneal injury in Balb/c male mice was induced by thermal cautery. Wound healing, re–epithelialization, opacity and neo–vascularization were assessed by slit lamp vital microscopy. Eyes or cornea were collected at different stages of wound healing and inflammatory markers quantitated by ELISA, myeloperoxidase assay, and/or RT–PCR. Oligonucleotide primers were designed to quantitate RNA expression of 12/15–lipoxygenase and the LXA4 receptor. 17S–series resolvins were biosynthesized from DHA and purified by column chromatography and RP–HPLC. Mice were treated with 1 µg LXA4 or the resolvin precursor 17S–hydroxy–DHA by eye drop and tail vein injection for 4 days post–injury. Results: Eye and cornea expressed 12/15–lipoxygenase, a key enzyme for the formation of lipoxins and resolvins, as well as the LXA4 receptor. Treatment with either LXA4 or 17S–hydroxy–DHA caused a pronounced inhibition of corneal neo–vascularization, inflammation and corneal opacity and dramatically accelerated wound repair. Conclusions: Taken together these findings provide the first evidence for anti–inflammatory lipid circuits in the cornea, namely expression of their biosynthetic pathways as well as receptors. The dramatic impact of LXA4 and 17S–Resolvins on wound repair and neo–vascularization provides evidence for a potential role for these endogenous lipid circuits in minimizing corneal damage. Moreover, they may provide a novel therapeutic approach to accelerate or promote corneal healing following injury or refractive surgery.

Keywords: cornea: epithelium • inflammation • wound healing 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×